US Stock MarketDetailed Quotes

OKUR OnKure Therapeutics

Watchlist
  • 9.860
  • -0.970-8.96%
Close Dec 13 16:00 ET
  • 9.640
  • -0.220-2.23%
Post 17:34 ET
131.53MMarket Cap-1.00P/E (TTM)

OnKure Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-77.67%4.66M
66.12%14.34M
12.33%9.83M
24.08%36.93M
-21.11M
20.89M
8.63M
8.75M
29.77M
Selling and administrative expenses
-48.25%3.76M
220.63%3.59M
2.93%1.27M
23.44%4.82M
---14.22M
--7.27M
--1.12M
--1.23M
--3.9M
-General and administrative expense
-48.25%3.76M
220.63%3.59M
2.93%1.27M
23.44%4.82M
---14.22M
--7.27M
--1.12M
--1.23M
--3.9M
Research and development costs
-93.36%904K
43.09%10.75M
13.86%8.57M
24.18%32.12M
---6.89M
--13.62M
--7.51M
--7.52M
--25.86M
Operating profit
77.67%-4.66M
-66.12%-14.34M
-12.33%-9.83M
-24.08%-36.93M
21.11M
-20.89M
-8.63M
-8.75M
-29.77M
Net non-operating interest income expense
-54.77%204K
304.11%295K
538.98%1.62M
451K
73K
254K
Non-operating interest income
----
-49.00%230K
304.11%295K
538.98%1.62M
----
----
--451K
--73K
--254K
Non-operating interest expense
----
--26K
----
----
----
----
--0
----
----
Other net income (expense)
-42.55%972K
1.69M
Other non- operating income (expenses)
-42.55%972K
----
----
----
----
--1.69M
----
----
----
Income before tax
80.77%-3.69M
-72.79%-14.14M
-9.87%-9.54M
-19.65%-35.31M
18.52M
-19.2M
-8.18M
-8.68M
-29.51M
Income tax
Net income
80.77%-3.69M
-72.79%-14.14M
-9.87%-9.54M
-19.65%-35.31M
18.52M
-19.2M
-8.18M
-8.68M
-29.51M
Net income continuous Operations
80.77%-3.69M
-72.79%-14.14M
-9.87%-9.54M
-19.65%-35.31M
--18.52M
---19.2M
---8.18M
---8.68M
---29.51M
Minority interest income
Net income attributable to the parent company
80.77%-3.69M
-72.79%-14.14M
-9.87%-9.54M
-19.65%-35.31M
18.52M
-19.2M
-8.18M
-8.68M
-29.51M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
80.77%-3.69M
-72.79%-14.14M
-9.87%-9.54M
-19.65%-35.31M
18.52M
-19.2M
-8.18M
-8.68M
-29.51M
Basic earnings per share
80.77%-0.2768
-72.79%-1.0599
-9.87%-0.7149
-19.65%-2.6471
1.3886
-1.439
-0.6134
-0.6506
-2.2124
Diluted earnings per share
80.77%-0.2768
-72.79%-1.0599
-9.87%-0.7149
-19.65%-2.6471
1.3886
-1.439
-0.6134
-0.6506
-2.2124
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022
Total revenue 000000000
Operating revenue --0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -77.67%4.66M66.12%14.34M12.33%9.83M24.08%36.93M-21.11M20.89M8.63M8.75M29.77M
Selling and administrative expenses -48.25%3.76M220.63%3.59M2.93%1.27M23.44%4.82M---14.22M--7.27M--1.12M--1.23M--3.9M
-General and administrative expense -48.25%3.76M220.63%3.59M2.93%1.27M23.44%4.82M---14.22M--7.27M--1.12M--1.23M--3.9M
Research and development costs -93.36%904K43.09%10.75M13.86%8.57M24.18%32.12M---6.89M--13.62M--7.51M--7.52M--25.86M
Operating profit 77.67%-4.66M-66.12%-14.34M-12.33%-9.83M-24.08%-36.93M21.11M-20.89M-8.63M-8.75M-29.77M
Net non-operating interest income expense -54.77%204K304.11%295K538.98%1.62M451K73K254K
Non-operating interest income -----49.00%230K304.11%295K538.98%1.62M----------451K--73K--254K
Non-operating interest expense ------26K------------------0--------
Other net income (expense) -42.55%972K1.69M
Other non- operating income (expenses) -42.55%972K------------------1.69M------------
Income before tax 80.77%-3.69M-72.79%-14.14M-9.87%-9.54M-19.65%-35.31M18.52M-19.2M-8.18M-8.68M-29.51M
Income tax
Net income 80.77%-3.69M-72.79%-14.14M-9.87%-9.54M-19.65%-35.31M18.52M-19.2M-8.18M-8.68M-29.51M
Net income continuous Operations 80.77%-3.69M-72.79%-14.14M-9.87%-9.54M-19.65%-35.31M--18.52M---19.2M---8.18M---8.68M---29.51M
Minority interest income
Net income attributable to the parent company 80.77%-3.69M-72.79%-14.14M-9.87%-9.54M-19.65%-35.31M18.52M-19.2M-8.18M-8.68M-29.51M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 80.77%-3.69M-72.79%-14.14M-9.87%-9.54M-19.65%-35.31M18.52M-19.2M-8.18M-8.68M-29.51M
Basic earnings per share 80.77%-0.2768-72.79%-1.0599-9.87%-0.7149-19.65%-2.64711.3886-1.439-0.6134-0.6506-2.2124
Diluted earnings per share 80.77%-0.2768-72.79%-1.0599-9.87%-0.7149-19.65%-2.64711.3886-1.439-0.6134-0.6506-2.2124
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSD
Heat List
US
Overall
Symbol
Price
% Chg

No Data